Metabolically compromised cells may be subject to complement-mediated cytotoxicity. The aim of this study was to clarify to what extent plasma complement C3 might contribute to the low survival (5-20%) of grafted dopaminergic neurons. The survival of intrastriatal cell suspension grafts of syngeneic dopaminergic, tyro sine hydroxylase (TH)-containing neurons was compared in rats subjected to short-term IV treatment with 1) cobra venom factor (CVF), or 2) placebo treatment. Depletion of plasma complement C3 by CVF was confirmed by crossed immunoelectrophoresis. With 159 + 37 (mean + SEM) TH-immunoreactive and 154 ± 40 TH mRNA-expressing neurons in the CVF-treated rats (n = 9), and 117 + 34 TH-immunoreactive and 160 ± 49 TH mRNA-expressing neurons in placebo rats (n = 6), the CVF treatment did not increase the survival of the grafted dopaminergic neurons. Similarly, CVF had no apparent effect on the astroglial, mi croglial, or oligodendroglial cell response within and around the graft. The data indicate that depletion of plasma complement C3 at the time of grafting has no effect on the long-term survival of syngeneic ventral mesencephalic dopaminergic neuronal grafts.
INTRODUCTION
Intracerebral grafting of embryonic dopaminergic (DA) neurons is being used in experimental clinical medicine to alleviate neurological symptoms in patients with severe Parkinson's disease (27) . Both basic experi mental and clinical graftings are complicated by the fact that only a small percentage (5-20%) of the grafted DA neurons survive (6) . In clinical trials it has thus been necessary to use donor tissue from several embryos in order to obtain sufficient numbers of surviving DA neu rons. This leads to practical problems regarding timing of abortions and graftings, and it raises significant ethi cal problems. It has been successfully attempted to in crease the survival of grafted DA cells by improving the preparation techniques (2) and by short-term pretreat ment of the dissociated mesencephalic donor tissue with lazaroids (5,34,36), gangliosides (12, 35) , and neurotro phic factors (23, 24) . A considerable effect has been ob served after treatment of DA neurons with basic fibro blast growth factor (bFGF), which in a dose-dependent manner has been shown to increase the survival of DA neurons (from almost 0% to 50%) in vitro, but the effect is very modest in vivo (30, 31) .
A contributing factor to the low survival rate of the grafted neurons might be unspecific inflammatory reac tions, mediated by free radicals, cytolytic proteases and cytotoxic cytokines released by infiltrating leukocytes, and activated glial cells, as well as complement-medi ated cytotoxicity. The acute trauma-induced inflamma tory reactions are initially identical around grafts of syn-, alio-, and xenogeneic brain tissue, being characterized with blood-brain barrier (BBB) leakage with subsequent leukocyte recruitment and activation of brain astroglial and microglial cells (13, 16, 29) . As a consequence of leakage of the BBB plasma leaks into grafts and host neuropil (7, 16, 41) . This creates a situation where the do nor cells for a few days after grafting are exposed to plasma proteins, including complement factors, which might be cytotoxic not only to xeno-and allogeneic but also to syngeneic donor cells. In contrast to organ trans plantations, where large blood vessels of grafts are sur gically anastomosed with blood vessels of the recipients, the vascularization and reperfusion of grafts in the brain is delayed for days (25) . The delayed reperfusion creates a situation where the donor cells cannot provide enough adenosine triphosphate to maintain their normal asym metric membrane structure (22) . This may lead to expo-sure of phospholipids on the surface of the cell, which will be hydrolyzed by secretory phospholipase A 2 (sPLA 2 ), generating lysophosphatidyl-choline (lyso-PC) and thereby binding sites for C-reactive protein (CRP). If the complement system is functioning within the brain parenchyma, as in other transplantation sites, creation of binding sites for CRP may lead to activation of the complement system via the classical pathway (22) . The complement system exerts the effect on target cells by opsonization, lysis, and activation of leukocytes. Activa tion of the complement system gives rise to the genera tion of split products, such as C3a and C5a, which con tribute to the inflammatory reaction (33) . Complement activation plays a pivotal role in the inflammatory reac tions caused by reperfusion injury (10, 43) . It has been demonstrated that this condition can be improved by in hibiting the complement system (48) .
The aim of this study was to elucidate to which ex tent activation of the plasma complement system might contribute to the low survival of grafted syngeneic DA neurons. The complement system was inactivated by depletion of C3 by injection of cobra venom factor (CVF), and the number and the density of surviving DA neurons were compared in complement-depleted and placebo-treated rats. In addition, astroglial, microglial, and oligodendroglial cell reactions were compared in CVF-and placebo-treated rats.
MATERIALS AND METHODS

Treatment With Cobra Venom Factor (CVF)
The effect of CVF on plasma complement C3 was evaluated in a pilot study. Two adult male Wistar Kyoto rats (M0llegaard, DK) weighing 250-300 g were under deep pentobarbital anesthesia (Mebumal, 50 mg/kg, SAD, DK) injected IV (vena dorsalis penis) on 2 subse quent days with CVF 30 U/kg per day (Quidel, UK). Blood was collected from the tail vein of treated rats at 0 and 24 h after the first injection, and at 24, 48, and 72 h after the second injection, and stored at 4°C for 24 h prior to centrifugation. Blood samples were centrifuged at 10,000 x g for 10 min and the plasma was frozen and stored at -20°C prior to analysis.
Crossed Immunoelectrophoresis (XIE)
XIE was performed in 2% agarose and 0.02 M Trisbarbital buffer, pH 8.6, as described by Teisner et al. (45) . The first dimension was performed at 10 V/cm, and was stopped when a bromophenol blue marker had migrated 5 cm. The second gel contained polyclonal sheep anti-C3 antibody (Biogenesis, UK, Cat. No. 2224-3804) diluted 1:300 in agarose and 0.02 M Tris-barbital buffer, pH 8.6. The second dimension electrophoresis was performed at 2.5 V/cm for 24 h.
Treatment of Recipient Rats With CVF and Saline
Fifteen adult male Wistar Kyoto rats obtained from M0llegaard (DK) and weighing 350-400 g were treated with CVF as described above 24 h prior to the intracere bral transplantation. Control rats (n = 7) received an IV injection of isotonic saline. Five CVF-treated rats died immediately after the first injection. The remaining 10 CVF-treated rats and all saline-treated control rats re ceived their second injection immediately after grafting.
Preparation of Cell Suspensions
Embryonic day 14 fetuses were removed from preg nant Wistar Kyoto rats (M0llegaard, DK) under deep pentobarbital anesthesia (Mebumal, 50 mg/ml, SAD, DK). The pregnant rats were thereafter immediately killed by decapitation. The fetal brains were removed and the ventral mesencephalon isolated. The dissected tissue fragments were incubated in medium containing 0.01% DNase (0.5 mg/5 ml, Sigma, UK, D-5025) and 0.1% trypsin (5 mg/5 ml, Sigma, UK, T-8128) in Gay's balanced salt solutions (GBSS, Life Technologies, DK) for 20 min at 37°C (14) . The tissue fragments were then washed four times with GBSS and triturated through the tips of fire-polished pasteur pipettes until a homogenous cell suspension was obtained. Viability of the cell sus pension was measured using a 0.4% trypan blue solution (Sigma, T-8154) diluted 1:9 in GBSS. By using the for mula, cell survival % = 100 x NI(N + A/ Muc ), the viabil ity of the cell suspension was found to be 89% after grafting.
Transplantation Procedure
Ten CVF-treated and seven isotonic saline-treated adult male Wistar Kyoto rats were used as recipients. Under deep pentobarbital anesthesia (Mebumal, 50 mg/ ml, SAD, DK) rats were placed in a stereotaxic device. Transplantation was performed by injection of 4 ul cell suspension into the left striatum, using a 10-ul Hamilton microsyringe. Coordinates in relation to bregma were 0.5 mm anterior, 3.0 mm lateral, and 5.0 mm ventral to the dura, with incisor bar set at -2.5 mm. Postoperative treatment consisted of a single injection of 30 U/kg CVF («=10) or isotonic saline (n = 7). Postoperative pain treatment consisted of 0.2 ml Buprenorphinum (Temgesic, Reckitt and Colman, UK) injected SC.
Weight Monitoring
The weight of the recipient rats was monitored at 0, 
GFAP, OX42, and RIP Immunohistochemistry
Series of brain sections were processed with GFAP, 0X42, or RIP antibodies in order to visualize astrocytes, macrophages/microglia, and oligodendroglia, respec tively, using the avidin/streptavidin peroxidase method ( Table 1 ). The staining procedures were as described above with the only modification that the secondary an tibody used to recognize the primary monoclonal OX42 and RIP antibodies was biotinylated anti-mouse anti body.
In Situ Hybridization
One series of sections was hybridized using an alkaline-phosphatase (AP)-labeled oligodeoxynucleotide probe 
Cell Counts
All TH-immunoreactive (TH-ir) and TH mRNAexpressing neurons were counted in the graft sections using a xlOO oil objective, and the area of the grafts was determined by utilizing the computer program CASTGRID (Olympus, DK). In brief, the microscope images obtained by a xlO objective were projected on the computer screen, and the total area of the graft was circumferenced and measured. The total graft area was calculated as the sum of graft areas measured in graftcontaining sections from each animal. Cell counting was carried out by positioning an unbaised counting frame of known area, A frame = 6000 um 2 , in a lattice with interpoint (x,y) distance of 60 um x 100 pm, yielding an interpoint area, A { x,y) = 6000 pm 2 
. The estimated number of neurons (AO within the counted sections was calcu lated as N = A { x,y) x Q/A fIltmc ,
where Q is the total num ber of counted neurons. This accordingly means that the entire graft was sampled and all labeled neurons were counted. The criteria for counting a neuron was that the stained neuron contained a visible nucleus. Double counting of cells showed that the variability in the cell counting was below 3% within individual animals.
The total number of surviving DA neurons within each graft was estimated according to Abercrombie's formula (1): P = AM/(L + M), where P is the average number of nuclear points per section, A is the number of nuclei counted in the section, M is the thickness (50 pm) of the section, and L the average length (pm) of the nuclei. The average diameter of the nuclei of the TH-ir neurons in the present study was 6.4 ± 0.1 pm.
By using EXCEL computer program the mean num bers ± SEM of TH-ir and TH mRNA-expressing neu rons, and TH-ir neurons/area (mm 2 ) were calculated. The p-values were estimated by two-way analysis of variance (ANOVA).
RESULTS
Crossed Immunoelectrophoresis
The results of crossed immunoelectrophoresis of plas ma complement C3 are shown in Figure 1 . C3 was de pleted 24 h after the first CVF injection and remained depleted 72 h after the second CVF injection. The con tinued presence of low levels' of plasma complement C3 in the treated animals can be attributed to new synthesis of C3. There was no sign of C3 split products, suggest ing fast elimination of these products.
Weight Monitoring
Monitoring of the general health condition and the weight of the transplanted animals showed normal gain of weight in CVF-and saline-treated rats.
Survival of TH-ir and TH mRNA-Expressing Dopaminergic Neurons
Two (one in each treatment group) out of 17 rats con tained no viable graft, and three grafts were partially in the placebo treatment group. Comparison of these numbers showed that CVF treatment had no significant effect on the survival of the grafted DA neurons (p > 0.05) (Fig. 4) .
CVF CON
The density of TH-ir cells was 75+9 TH-ir cells/ mm 2 in the CVF treatment group, and 64 ±11 TH-ir cells/mm 2 in the placebo treatment group. The CVF treatment had no significant effect on the density of sur viving DA neurons within the grafts (p > 0.05) (Fig. 4) . The density of TH mRNA-expressing neurons was not estimated due to difficulties in making an accurate dis tinction between graft and host tissue in the in situ hy bridized sections.
GFAP, 0X42, and RIP Immunohistochemistry
Immunohistochemical staining for GFAP revealed numerous hypertrophic astrocytes at the transplant-host interface (Fig. 5A, B) . Immunostaining with 0X42 anti body showed accumulation of macrophages/microglia at the transplant-host interface, and resting-like microglia both within and around the graft (Fig. 5C, D) . RlP-immunoreactive oligodendrocytes and myelinated nerve fi bers were present in high density within the grafts (Fig.  5E, F) . The morphology and distribution of GFAP, OX42, and RIP-ir cells appeared to be similar in the two treatment groups.
DISCUSSION
The complement system has been shown to play a role in the pathogenesis of central nervous diseases like Alzheimer disease (40) , multiple sclerosis (44) , and ex perimental allergic encephalomyelitis (28) . The purpose of this study was to investigate whether activation of the plasma complement system might influence the survival of syngeneic DA neurons transplanted into the intact rat striatum. Depletion of plasma complement C3 was achieved by treatment with CVF as confirmed by crossed immunoelectrophoresis. The results of the study showed that depletion of plasma complement C3 at the time of grafting had no effect on: 1) the survival and density of grafted DA neurons, or 2) the survival of the nonneuronal cellular components of the graft. The latter is demonstrated by a similar distribution and morphol ogy of microglial, astroglial, and oligodendroglial cells and a similar density of DA neurons within the grafts in either treatment group.
The BBB provides a physical barrier that restricts passage of large molecules into the brain parenchyma. The transplantation procedure causes leakage of the BBB (7, 16) , and large molecules, including plasma complement, accordingly reach the brain parenchyma and the graft, which has a leaky BBB for the first few weeks after grafting (41) . During this period activation of extravasated complement factors may give rise to: 1) binding of complement components to donor cells, which facilitates their phagocytosis by brain macro phages, 2) generation of the membrane attack complex (MAC) that directly lyses donor cells, or 3) generation of split products that attract leukocytes to the site of graft.
The complement system consists of at least three acti vation pathways, which are the classical pathway, the alternative pathway, and the mannan-binding lectin path way. Complement component C3 plays a key role in the activation of effector mechanisms in all three pathways (46) . By using CVF, which activates the alternative pathway leading to C3 cleavage and consumption (47) , we demonstrated that short-term depletion of plasma complement has no harmful effects on the long-term survival of grafted syngeneic DA neurons or the non neuronal cellular components of the graft, despite the presence of a leaky BBB. We also demonstrated that treatment of rats with CVF will deplete the plasma com plement C3, but not completely, as has been claimed in other studies (26) . The lack of effect of the CVF treat ment protocol may be due to deleterious effects of newly synthesized C3 on the grafts. Complete depletion of plasma complement and locally synthesized complement by glial cells and infiltrating macrophages could be effi ciently achieved by using C3-deficient recipient animals. Other inhibitors of the complement system, like decayaccelerating factor and CD59, have been used to de crease the complement cytotoxic effect on donor cells in vitro (8, 11) .
Previous studies carried out by our group have shown that both allogeneic rat grafts and murine xenografts be come populated by host hematopoietic cells (18, 38) , which migrate and differentiate into both microglia and macroglia in the brain (15) . There is now evidence that astrocytes and microglia can be induced by injury in vivo (3, 32, 37) and by cytokines like interferon-gamma and tumor necrosis factor in vitro (3, 20, 32, 42) , to pro duce complement components. There are, to our knowl edge, no published data on the potential effect of CVF on the C3 synthesis by infiltrating macrophages, and ac tivated astrocytes and microglia. Nevertheless, we as sume that CVF, by having structural homology with C3 (47), may pass through the leaky BBB and might deplete C3 synthesized locally by activated glial cells and infil trating macrophages.
The fact that the immunohistochemical staining by the OX42 antibody in the present study demonstrated similar macrophage/microglia reactions at the site of the graft in either treatment groups may be explained by the fact that the macrophage/microglia and leukocyte reac-FACING PAGE Figure 5 . Immunohistochemical stainings of astroglial (A, B), microglial (C, D), and oligodendroglial cells and myelin (E, F) performed on parallel sections from CVF-treated recipient rat. GFAP immunostaining showing hypertrophic astrocytes (arrows) at the graft-host interface (A). High magnification of GFAP-positive astrocytes (arrows) (B). OX42 immunostaining showing accumulation of macrophages/microglia (arrows) at the graft-host interface (C). High magnification of macrophages/microglia (D). RIP-ir oligodendrocytes and myelinated nerve fibers are present (arrows) in high density both within the graft and the host striatum (E). RIP-ir oligodendrocyte cell bodies can be seen at a higher magnification (F). The distribution and morphology of GFAP, OX42, and RIP-ir cells are similar in the CVF-and placebo-treated groups of rats (G, graft. STR, striatum). Bars: 330 pm (A, C, E); 20 um (B, D, F). tions are unaffected by CVF treatment or that they nor malize after discontinuing the CVF treatment.
In summary, the comparison of the number and den sity of DA neurons, and the distribution and morphology of astrocytes, microglia, and oligodendrocytes in the two treatment groups leads us to conclude that short-term CVF treatment has no effect on the long-term survival, trophism, and characteristics of syngeneic DA grafts, just as it does not prevent migration of host macro phages/microglia into the grafts and their differentiation into microglia. The study leaves open the possibility that C3 depletion may enhance the survival of grafted alloand xenogeneic DA grafts.
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